Jillian Michaels Exposes Oprah Winfrey’s Financial Ties to Ozempic Weight Loss Drug

Los Angeles, CA – Fitness instructor Jillian Michaels has raised speculation that media mogul Oprah Winfrey may be benefiting financially from the weight loss drug Ozempic. Michaels, 49, made these claims in an exclusive interview with Page Six. She points out that Winfrey is a major shareholder of WeightWatchers and that the company is now involved in the Ozempic business. Michaels suggests that this creates a financial incentive for Winfrey to promote the drug.

Michaels argues that WeightWatchers purchased a company that provides access to weight loss drugs, which now creates a financial interest in the success of these drugs. Winfrey has not responded to requests for comment on the matter.

Winfrey became an ambassador for WeightWatchers in the same year that she bought a stake in the company. She publicly praised the brand for helping her lose 40 pounds. However, Winfrey’s admission of using an unspecified weight loss medication in December 2023 raised eyebrows, especially since she had previously suggested that relying on a drug like Ozempic was “the easy way out.”

WeightWatchers has recently expanded its offerings to include “doctor-led access to prescription medication,” including Ozempic, which is used to treat Type 2 diabetes. The company’s CEO, Sima Sistani, has stated that they aim to destigmatize conversations around obesity and better serve their customers.

While Winfrey stands by WeightWatchers and their program, Michaels believes that her financial interest in the weight loss industry may influence her promotion of Ozempic. This controversy highlights the ongoing debate surrounding the use of weight loss drugs and the potential conflicts of interest in the industry.

It is important to note that Michaels’ claims are speculative and there is no concrete evidence to support them. However, the discussion around Winfrey’s involvement with Ozempic raises questions about the influence of celebrity endorsements in the weight loss industry.

Oprah Winfrey has been open about her struggles with weight and has used her platform to advocate for body positivity and self-acceptance. Her decision to use weight loss medication reflects her personal journey and desire to manage her weight in a way that works for her.

The controversy surrounding Winfrey and Ozempic serves as a reminder of the complex nature of the weight loss industry and the various factors that can influence the choices and endorsements of public figures. It remains to be seen how this controversy will impact Winfrey’s reputation and the WeightWatchers brand.